Pursuant to the provisions of Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you ....
ELITECON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Elitecon International Ltd (formerly Kashiram Jain & Company) reported a massive jump in revenues for the quarter and nine months ended December 31, 2025. On a consolidated basis, revenue from operations rose to Rs. 547,689 lakhs for 9M FY26 versus Rs. 23,560 lakhs in 9M FY25, driven by both the Tobacco and FMCG segments. Consolidated profit after tax for 9M FY26 stood at Rs. 31,117 lakhs versus Rs. 2,668 lakhs in 9M FY25. On a standalone basis, 9M FY26 revenue was Rs. 120,685 lakhs (vs. Rs. 17,710 lakhs last year) and PAT was Rs. 5,012 lakhs (vs. Rs. 2,000 lakhs). The company underwent a stock split from Rs. 10 to Rs. 1 face value in June 2025. The auditor (V.N. Purohit & Co.) issued an unmodified limited review report with several Emphasis of Matter paragraphs flagging a DGGI GST show cause notice, Firozabad unit refund disputes, a recent FDA seizure of tobacco inventory and machines at the Nashik plant, an insolvency petition filed by Advik Capital before the NCLT, and a pending QIP linked to its Sunbridge Agro and Landsmill Agro acquisitions.
Headline numbers show explosive top-line and bottom-line growth on the back of newly consolidated subsidiaries, which should be positive for the stock in the short term. However, shareholders should weigh this against multiple regulatory overhangs — a pending GST show cause notice spanning Oct 2020–Oct 2024, the FDA seizure of tobacco inventory/machinery in Jan 2026, and an active insolvency petition at NCLT by Advik Capital — all of which carry potential financial and operational risk.